STOCK TITAN
  1. Home
  2. Sec-filings
  3. TDOC
  4. [Form 4] Teladoc Health, Inc. Insider Trading Activity

Teladoc (NYSE: TDOC) director receives 30,441 RSUs equity award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Smith Mark Douglas reported acquisition or exercise transactions in this Form 4 filing.

Teladoc Health director Mark Douglas Smith received a grant of 30,441 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Teladoc common stock. The RSUs vest in full on the earlier of May 21, 2027 or the day immediately before Teladoc’s 2027 annual shareholder meeting.

Vested shares will be delivered to Smith upon the earliest of several events: within a specified period after separation of service, around the time of a qualifying Change of Control as defined in Teladoc’s Deferred Compensation Plan for Non-Employee Directors, or upon his death. This is a compensation-related equity award, not an open-market stock purchase or sale.

Positive

  • None.

Negative

  • None.
Insider Smith Mark Douglas
Role Director
Type Security Shares Price Value
Grant/Award Restricted Stock Units 30,441 $0.00 $0.00
Holdings After Transaction: Restricted Stock Units — 30,441 shares (Direct)
Footnotes (2)
  1. F1. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
  2. F2. The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death.
RSUs granted 30,441 units Restricted Stock Units granted to director on May 21, 2026
Underlying common shares 30,441 shares Each RSU represents one share of common stock
RSU vesting date May 21, 2027 Vests earlier of May 21, 2027 or day before 2027 annual meeting
Post-grant RSU holdings 30,441 units Total RSUs held directly following this grant
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share of TDOC common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Change of Control financial
"immediately prior to, on or within 30 days following a Change of Control"
A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.
Deferred Compensation Plan for Non-Employee Directors financial
"as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transaction did Teladoc Health (TDOC) disclose for Mark Douglas Smith?
Teladoc Health disclosed that director Mark Douglas Smith received a grant of 30,441 restricted stock units. These RSUs are a stock-based compensation award and each unit represents a contingent right to receive one share of Teladoc common stock in the future.

How many Teladoc (TDOC) restricted stock units were granted to the director?
The director received 30,441 restricted stock units from Teladoc Health. After this grant, his reported derivative holdings in these RSUs total 30,441 units, all held directly as a compensation award rather than purchased on the open market.

When do the newly granted Teladoc (TDOC) RSUs vest for the director?
The RSUs vest in full on the earlier of May 21, 2027 or the day immediately preceding Teladoc’s 2027 annual meeting of stockholders. This single vesting date structure means the entire 30,441-unit award vests at once rather than in installments.

Under what conditions will Teladoc (TDOC) deliver shares from the director’s RSUs?
Vested shares will be delivered on the earliest of three events: within a set period after the director’s separation of service, around the time of a qualifying Change of Control under Teladoc’s non-employee director deferred compensation plan, or upon the director’s death.

Does the Teladoc (TDOC) Form 4 show any insider stock sales or purchases?
The Form 4 shows only an acquisition of 30,441 restricted stock units as a grant, with no reported open-market stock purchases or sales. It is purely a compensation-related equity award to a Teladoc non-employee director, not a discretionary trading transaction.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Smith Mark Douglas
(Last)(First)(Middle)
C/O TELADOC HEALTH, INC.,
155 E 44TH ST, FLOOR 17
(Street)
NEW YORK NEW YORK 10017
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Teladoc Health, Inc. [ TDOC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)05/21/2026A30,441 (2) (2)Common Stock30,441$030,441D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
2. The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death.
Remarks:
/s/ Adam C. Vandervoort, Attorney-in-Fact05/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR